{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:42:02Z","timestamp":1788381722612,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00431-019-03330-x","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:44:00Z","timestamp":1549827840000},"page":"593-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion"],"prefix":"10.1007","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3052-2366","authenticated-orcid":false,"given":"Nathalie","family":"Guffon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Journeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Brassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Leger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"issue":"6","key":"3330_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jpeds.2008.12.024","volume":"154","author":"P Arn","year":"2009","unstructured":"Arn P, Wraith J, Underhill L et al (2009) Characterization of surgical procedures in patients with mucopolysaccharidosis type I, findings from the MPS I Registry. J Pediatr 154(6):859\u2013864. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2008.12.024","journal-title":"J Pediatr"},{"key":"3330_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","volume":"28","author":"F Baehner","year":"2005","unstructured":"Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlsch\u00fctter A, Kampmann C, Beck M (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011\u20131017. \n                    https:\/\/doi.org\/10.1007\/s10545-005-0112-z","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"3330_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/gim.2014.25","volume":"16","author":"JM Beck","year":"2014","unstructured":"Beck JM, Arn P, Giugliani R et al (2014) The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med 16(10):759\u2013765. \n                    https:\/\/doi.org\/10.1038\/gim.2014.25","journal-title":"Genet Med"},{"issue":"5","key":"3330_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0036-1584602","volume":"47","author":"JJ Boelens","year":"2016","unstructured":"Boelens JJ, van Hasselt PM (2016) Neurodevelopmental outcome after hematopoietic cell transplantation in inborn errors of metabolism: current considerations and future perspectives. Neuropediatrics 47(5):285\u2013292. \n                    https:\/\/doi.org\/10.1055\/s-0036-1584602","journal-title":"Neuropediatrics"},{"key":"3330_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ymgmr.2016.07.006","volume":"8","author":"S Bruni","year":"2016","unstructured":"Bruni S, Lavery C, Broomfield A (2016) The diagnostic journey of patients with mucopolysaccharidosis I: a real-world survey of patient and physician experiences. Mol Genet Metab Rep 8:67\u201373. \n                    https:\/\/doi.org\/10.1016\/j.ymgmr.2016.07.006","journal-title":"Mol Genet Metab Rep"},{"key":"3330_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3346\/jkms.2014.29.2.254","volume":"29","author":"SY Cho","year":"2014","unstructured":"Cho SY, Huh I, Chang MS et al (2014) Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome). J Korean Med Sci 29:254\u2013260. \n                    https:\/\/doi.org\/10.3346\/jkms.2014.29.2.254","journal-title":"J Korean Med Sci"},{"key":"3330_CR7","doi-asserted-by":"publisher","unstructured":"Cimaz R, Coppa GV, Kon\u00e9-Paut I, Link B, Pastores GM, Elorduy MR, Spencer C, Thorne C, Wulffraat N, Manger B (2009) Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J 7(18). \n                    https:\/\/doi.org\/10.1186\/1546-0096-7-18.","DOI":"10.1186\/1546-0096-7-18."},{"key":"3330_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1542\/peds.2007-3847","volume":"123","author":"LA Clarke","year":"2009","unstructured":"Clarke LA, Wraith JE, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Sidman M, Kakkis ED, Cox GF (2009) Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123:229\u2013240. \n                    https:\/\/doi.org\/10.1542\/peds.2007-3847","journal-title":"Pediatrics"},{"key":"3330_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00431-013-1967-x","volume":"172","author":"GM Cohn","year":"2013","unstructured":"Cohn GM, Morin I, Whiteman DA (2013) Development of a mnemonic screening tool for identifying subjects with Hunter syndrome. Eur J Pediatr 172:965\u2013970. \n                    https:\/\/doi.org\/10.1007\/s00431-013-1967-x","journal-title":"Eur J Pediatr"},{"issue":"6","key":"3330_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","volume":"171","author":"K D\u2019Aco","year":"2012","unstructured":"D\u2019Aco K, Underhill L, Rangachari L et al (2012) Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry. Eur J Pediatr 171(6):911\u2013919. \n                    https:\/\/doi.org\/10.1007\/s00431-011-1644-x","journal-title":"Eur J Pediatr"},{"key":"3330_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ymgmr.2017.07.012","volume":"13","author":"JB Eisengart","year":"2017","unstructured":"Eisengart JB, Jarnes J, Ahmed A, Nestrasil I, Ziegler R, Delaney K, Shapiro E, Whitley C (2017) Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome. Mol Genet Metab Rep 13:64\u201368. \n                    https:\/\/doi.org\/10.1016\/j.ymgmr.2017.07.012","journal-title":"Mol Genet Metab Rep"},{"key":"3330_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10545-010-9262-8","volume":"34","author":"CJ Gardner","year":"2011","unstructured":"Gardner CJ, Robinson N, Meadows T, Wynn R, Will A, Mercer J, Church HJ, Tylee K, Wraith JE, Clayton PE (2011) Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H). J Inherit Metab Dis 34:489\u2013497. \n                    https:\/\/doi.org\/10.1007\/s10545-010-9262-8","journal-title":"J Inherit Metab Dis"},{"issue":"4 suppl","key":"3330_CR13","doi-asserted-by":"publisher","first-page":"v924","DOI":"10.1590\/S1415-47572012000600006","volume":"35","author":"R Giugliani","year":"2012","unstructured":"Giugliani R (2012) Mucopolysacccharidoses: from understanding to treatment, a century of discoveries. Genet Mol Biol 35(4 suppl):v924\u2013v931","journal-title":"Genet Mol Biol"},{"issue":"2","key":"3330_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1590\/S1415-47572014000300003","volume":"37","author":"R Giugliani","year":"2014","unstructured":"Giugliani R, Villarreal ML, Valdez CA et al (2014) Guidelines for diagnosis and treatment of Hunter syndrome for clinicians in Latin America. Genet Mol Biol 37(2):315\u2013329","journal-title":"Genet Mol Biol"},{"key":"3330_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","volume":"109","author":"P Harmatz","year":"2013","unstructured":"Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, Guffon N, Burton BK, Hendriksz CJ, Mitchell J, Martins A, Jones S, Guelbert N, Vellodi A, Hollak C, Slasor P, Decker C (2013) The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab 109:54\u201361. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2013.01.021","journal-title":"Mol Genet Metab"},{"issue":"2","key":"3330_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.12968\/hmed.2011.72.2.91","volume":"72","author":"C Hendriksz","year":"2011","unstructured":"Hendriksz C (2011) Improved diagnostic procedures in attenuated mucopolysaccharidosis. Br J Hosp Med 72(2):91\u201395","journal-title":"Br J Hosp Med"},{"key":"3330_CR17","first-page":"180","volume":"59","author":"M Hermanussen","year":"2003","unstructured":"Hermanussen M, Cole TJ (2003) The calculation of target height reconsidered. Horm Res 59:180\u2013183","journal-title":"Horm Res"},{"issue":"1","key":"3330_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ymgme.2013.03.001","volume":"109","author":"SA Jones","year":"2013","unstructured":"Jones SA, Parini R, Harmatz P, Giugliani R, Fang J, Mendelsohn NJ et al (2013) The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab 109(1):41\u201348. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.001","journal-title":"Mol Genet Metab"},{"issue":"5","key":"3330_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10067-013-2423-z","volume":"33","author":"A Jurecka","year":"2014","unstructured":"Jurecka A, Zakharova E, Malinova V, Voskoboeva E, Tylki-Szyma\u0144ska A (2014) Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature. Clin Rheumatol 33(5):725\u2013731. \n                    https:\/\/doi.org\/10.1007\/s10067-013-2423-z","journal-title":"Clin Rheumatol"},{"issue":"5","key":"3330_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/13543784.11.5.675","volume":"11","author":"ED Kakkis","year":"2002","unstructured":"Kakkis ED (2002) Enzyme replacement therapy for the mucopolysaccharide storage disorders. Expert Opin Investig Drugs 11(5):675\u2013685","journal-title":"Expert Opin Investig Drugs"},{"key":"3330_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.033","volume":"178","author":"S Laraway","year":"2016","unstructured":"Laraway S, Mercer J, Jameson E, Ashworth J, Hensman P, Jones SA (2016) Outcomes of long-term treatment with laronidase in patients with mucopolysaccharidosis type I. J Pediatr 178:219\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2016.08.033","journal-title":"J Pediatr"},{"issue":"2","key":"3330_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ando.2017.04.008","volume":"78","author":"J L\u00e9ger","year":"2017","unstructured":"L\u00e9ger J (2017) How should we investigate children with growth failure? Ann Endocrinol (Paris) 78(2):106\u2013107. \n                    https:\/\/doi.org\/10.1016\/j.ando.2017.04.008","journal-title":"Ann Endocrinol (Paris)"},{"issue":"suppl 5","key":"3330_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/rheumatology\/ker390","volume":"50","author":"TJ Lehman","year":"2011","unstructured":"Lehman TJ, Miller N, Norquist B, Underhill L, Keutzer J (2011) Diagnosis of the mucopolysaccharidoses. Rheumatology 50(suppl 5):41\u201348. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/ker390","journal-title":"Rheumatology"},{"issue":"4","key":"3330_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1517\/21678707.2016.1147948","volume":"4","author":"SH Lum","year":"2016","unstructured":"Lum SH, Jones SA, Ghosh A, Bigger BW, Wynn RF (2016) Hematopoietic stem cell transplant for the mucopolysaccharidoses. Expert Opinion Orphan Drugs 4(4):379\u2013393. \n                    https:\/\/doi.org\/10.1517\/21678707.2016.1147948","journal-title":"Expert Opinion Orphan Drugs"},{"issue":"4","key":"3330_CR25","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1111\/j.1651-2227.2011.02522.x","volume":"101","author":"J Marucha","year":"2012","unstructured":"Marucha J, Jurecka A, Syczewska M, R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska A, Tylki-Szyma\u0144ska A (2012) Restricted joint range of motion in patients with MPS II: correlation with height, age and functional status. Acta Paediatr 101(4):e183\u2013e188. \n                    https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02522.x","journal-title":"Acta Paediatr"},{"issue":"18","key":"3330_CR26","doi-asserted-by":"publisher","first-page":"30147","DOI":"10.1016\/j.ymgme.2018.03.004","volume":"S1096-7192","author":"M Melbouci","year":"2018","unstructured":"Melbouci M, Mason RW, Suzuki Y, Fukao T, Orii T, Tomatsu S (2018) Growth impairment in mucopylysaccharidoses. Mol Genet Metab S1096-7192(18):30147\u201330141. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2018.03.004","journal-title":"Mol Genet Metab"},{"issue":"6","key":"3330_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jbspin.2017.01.008","volume":"84","author":"S Mitrovic","year":"2017","unstructured":"Mitrovic S, Gouze H, Gossec L, Schaeverbeke T, Fautrel B (2017) Mucopolysaccharidoses seen in adults in rheumatology. Joint Bone Spine 84(6):663\u2013670. \n                    https:\/\/doi.org\/10.1016\/j.jbspin.2017.01.008","journal-title":"Joint Bone Spine"},{"issue":"2","key":"3330_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o AM, Tomatsu S, Gottesman GS, Smith M, Orii T (2007) International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30(2):165\u2013174. \n                    https:\/\/doi.org\/10.1007\/s10545-007-0529-7","journal-title":"J Inherit Metab Dis"},{"key":"3330_CR29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","volume":"146A","author":"AM Monta\u00f1o","year":"2008","unstructured":"Monta\u00f1o AM, Tomatsu S, Brusius A, Smith M, Orii T (2008) Growth charts for patients affected with Morquio A disease. Am J Med Genet A 146A:1286\u20131295. \n                    https:\/\/doi.org\/10.1002\/ajmg.a.32281","journal-title":"Am J Med Genet A"},{"issue":"6","key":"3330_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","volume":"53","author":"AM Monta\u00f1o","year":"2016","unstructured":"Monta\u00f1o AM, Lock-Hock N, Steiner RD, Graham BH, Szlago M, Greenstein R, Pineda M, Gonzalez-Meneses A, \u00c7oker M, Bartholomew D, Sands MS, Wang R, Giugliani R, Macaya A, Pastores G, Ketko AK, Ezg\u00fc F, Tanaka A, Arash L, Beck M, Falk RE, Bhattacharya K, Franco J, White KK, Mitchell GA, Cimbalistiene L, Holtz M, Sly WS (2016) Clinical course of Sly syndrome (mucopolysaccharidosis type VII). J Med Genet 53(6):403\u2013418. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2015-103322","journal-title":"J Med Genet"},{"key":"3330_CR31","doi-asserted-by":"publisher","first-page":"v19","DOI":"10.1093\/rheumatology\/ker397","volume":"50","author":"K Morishita","year":"2011","unstructured":"Morishita K, Petty RE (2011) Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology 50:v19\u2013v25. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/ker397","journal-title":"Rheumatology"},{"issue":"2","key":"3330_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","volume":"111","author":"J Muenzer","year":"2014","unstructured":"Muenzer J (2014) Early initiation of enzyme replacement therapy for the mucopolysaccharidoses. Mol Genet Metab 111(2):63\u201372. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2013.11.015","journal-title":"Mol Genet Metab"},{"key":"3330_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","volume":"90","author":"J Muenzer","year":"2007","unstructured":"Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A (2007) A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 90:329\u2013337. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2006.09.001","journal-title":"Mol Genet Metab"},{"key":"3330_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.bbadis.2011.07.013","volume":"1812","author":"E Oussoren","year":"2011","unstructured":"Oussoren E, Brands MM, Ruijter GJ, der Ploeg AT, Reuser AJ (2011) Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options. Biochim Biophys Acta 1812:1542\u20131556. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2011.07.013","journal-title":"Biochim Biophys Acta"},{"key":"3330_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s13244-013-0246-8","volume":"4","author":"S Palmucci","year":"2013","unstructured":"Palmucci S, Attina G, Lanza ML, Belfiore G, Cappello G, Foti PV, Milone P, Di Bella D, Barone R, Fiumara A, Sorge G, Ettorre GC (2013) Imaging findings of mucopolysaccharidoses: a pictorial review. Insights Imaging 4:443\u2013459. \n                    https:\/\/doi.org\/10.1007\/s13244-013-0246-8","journal-title":"Insights Imaging"},{"key":"3330_CR36","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ymgme.2016.01.009","volume":"117","author":"R Parini","year":"2016","unstructured":"Parini R, Jones SA, Harmatz PR, Giugliani R, Mendelsohn NJ (2016) The natural history of growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab 117:438\u2013446. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2016.01.009","journal-title":"Mol Genet Metab"},{"key":"3330_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ymgmr.2013.10.001","volume":"1","author":"P Patel","year":"2014","unstructured":"Patel P, Suzuki Y, Maeda M, Yasuda E, Shimada T, Orii KE, Orii T, Tomatsu S (2014) Growth charts for patients with Hunter syndrome. Mol Genet Metab Rep 1:5\u201318. \n                    https:\/\/doi.org\/10.1016\/j.ymgmr.2013.10.001","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"3330_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ymgme.2015.09.008","volume":"116","author":"SH Peck","year":"2015","unstructured":"Peck SH, O\u2019Donnell PJ, Kang JL, Malhotra NR, Dodge GR, Pacifici M, Shore EM, Haskins ME, Smith LJ (2015) Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs. Mol Genet Metab 116(3):195\u2013203. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2015.09.008","journal-title":"Mol Genet Metab"},{"issue":"5","key":"3330_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.24246","volume":"76","author":"M Poe","year":"2014","unstructured":"Poe M, Chagnon S, Escolar M (2014) Early treatment is associated with improved cognition in Hurler syndrome. Ann Neurol 76(5):747\u2013753","journal-title":"Ann Neurol"},{"issue":"1","key":"3330_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/PRM-2010-0106.","volume":"3","author":"LE Polgreen","year":"2010","unstructured":"Polgreen LE, Miller BS (2010) Growth patterns and the use of growth hormone in the mucopolysaccharidoses. J Pediatr Rehabil Med 3(1):25\u201338. \n                    https:\/\/doi.org\/10.3233\/PRM-2010-0106.","journal-title":"J Pediatr Rehabil Med"},{"key":"3330_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2014_333","volume":"18","author":"A Quartel","year":"2014","unstructured":"Quartel A, Hendriksz CJ, Parini R, Graham S, Lin P, Harmatz P (2014) Growth charts for individuals with mucopolysaccharidosis VI (Maroteaux\u2013Lamy Syndrome). JIMD Rep 18:1\u201311. \n                    https:\/\/doi.org\/10.1007\/8904_2014_333.","journal-title":"JIMD Rep"},{"issue":"3","key":"3330_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pedneo.2015.04.015","volume":"57","author":"A Rozdzynska-Swiatkowska","year":"2016","unstructured":"Rozdzynska-Swiatkowska A (2016) Can macrosomia or large for gestational age be predictive of MPS I, II, VI? Pediatr Neonatol 57(3):181\u2013187. \n                    https:\/\/doi.org\/10.1016\/j.pedneo.2015.04.015.","journal-title":"Pediatr Neonatol"},{"key":"3330_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12519-014-0517-6","volume":"11","author":"A R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska","year":"2014","unstructured":"R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska A, Jurecka A, Cie\u015blik J, Tylki-Szyma\u0144ska A (2014) Growth patterns in children with mucopolysaccharidosis I and II. World J Pediatr 11:226\u2013231. \n                    https:\/\/doi.org\/10.1007\/s12519-014-0517-6","journal-title":"World J Pediatr"},{"key":"3330_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0425-z","volume":"11","author":"M Rutten","year":"2016","unstructured":"Rutten M, Ciet P, van den Biggelaar R, Oussoren E, Langendonk JG, van der Ploeg AT, Langeveld M (2016) Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis. Orphanet J Rare Dis 11:50. \n                    https:\/\/doi.org\/10.1186\/s13023-016-0425-z","journal-title":"Orphanet J Rare Dis"},{"issue":"455","key":"3330_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","volume":"96","author":"IV Schwartz","year":"2007","unstructured":"Schwartz IV, Ribeiro MG, Mota JG et al (2007) A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Paediatr Suppl 96(455):63\u201370","journal-title":"Acta Paediatr Suppl"},{"key":"3330_CR46","unstructured":"Semp\u00e9 M, P\u00e9dron G, Roy-Pernot M-P. (1997) Auxologie m\u00e9thode et s\u00e9quences. Th\u00e9raplix. Paris; M\u00e9ditions ISBN: 2-905839-2."},{"issue":"2","key":"3330_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","volume":"90","author":"M Sifuentes","year":"2007","unstructured":"Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, Okazaki S, Huff K, Cox GF, Swiedler SJ, Kakkis ED (2007) A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 90(2):171\u2013180. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2006.08.007","journal-title":"Mol Genet Metab"},{"key":"3330_CR48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2106\/00004623-199608000-00004","volume":"78","author":"PJ Stasikelis","year":"1996","unstructured":"Stasikelis PJ, Sullivan CM, Phillips WA, Polard JA (1996) Slipped capital femoral epiphysis. Prediction of contralateral involvement. J Bone Joint Surg Am 78:1149\u20131155","journal-title":"J Bone Joint Surg Am"},{"key":"3330_CR49","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1371\/journal.pone.0140901.eCollection2015.","volume":"10","author":"DA Stevenson","year":"2013","unstructured":"Stevenson DA, Steiner RD (2013) Skeletal abnormalities in lysosomal storage diseases. Pediatr Endocrinol Rev 10:406\u2013416. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0140901.eCollection2015.","journal-title":"Pediatr Endocrinol Rev"},{"issue":"3","key":"3330_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","volume":"107","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Okuyama T, Suzuki Y, Sakai N, Takakura H, Sawada T, Tanaka T, Otomo T, Ohashi T, Ishige-Wada M, Yabe H, Ohura T, Suzuki N, Kato K, Adachi S, Kobayashi R, Mugishima H, Kato S (2012) Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. Mol Genet Metab 107(3):513\u2013520. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2012.09.004","journal-title":"Mol Genet Metab"},{"issue":"6","key":"3330_CR51","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10545-012-9474-1","volume":"35","author":"A Thumler","year":"2012","unstructured":"Thumler A, Miebach E, Lampe C, Pitz S, Kamin W, Kampmann C, Link B, Mengel E (2012) Clinical characteristics of adults with slowly progressing MPS VI: a case series. J Inherit Metab Dis 35(6):1071\u20131079. \n                    https:\/\/doi.org\/10.1007\/s10545-012-9474-1","journal-title":"J Inherit Metab Dis"},{"key":"3330_CR52","doi-asserted-by":"publisher","unstructured":"Tomatsu S, Monta\u00f1o AM, Oikawa H, Giugliani R, Harmatz P, Smith M, Suzuki Y, Orii T Impairment of body growth in mucopolysaccharidoses. In: Preedy VR, editor. Handbook of growth and growth monitoring in health and disease 1. New York: Springer; 2012. pp. 2091\u20132117. \n                    https:\/\/doi.org\/10.1007\/978-1-4419-1795-9_126.","DOI":"10.1007\/978-1-4419-1795-9_126."},{"key":"3330_CR53","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1080\/08035250510031584","volume":"94","author":"S Vijay","year":"2005","unstructured":"Vijay S, Wraith JE (2005) Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr 94:8727. \n                    https:\/\/doi.org\/10.1080\/08035250510031584","journal-title":"Acta Paediatr"},{"issue":"suppl 5","key":"3330_CR54","doi-asserted-by":"publisher","first-page":"v26","DOI":"10.1093\/rheumatology\/ker393","volume":"50","author":"KK White","year":"2011","unstructured":"White KK (2011) Orthopaedic aspects of mucopolysaccharidoses. Rheumatology (Oxford) 50(suppl 5):v26\u2013v33","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3330_CR55","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","volume":"144","author":"JE Wraith","year":"2004","unstructured":"Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144(5):581\u2013588. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.046","journal-title":"J Pediatr"},{"issue":"3","key":"3330_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","volume":"167","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Meldgaard Lund A, Malm G, Van der Ploeg AT, Zeman J (2008) Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167(3):267\u2013277","journal-title":"Eur J Pediatr"},{"issue":"2","key":"3330_CR57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","volume":"117","author":"H Yabe","year":"2016","unstructured":"Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, Shintaku H, Suzuki Y, Orii T, Tomatsu S (2016) Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab 117(2):84\u201394. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2015.09.011","journal-title":"Mol Genet Metab"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-019-03330-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-019-03330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-019-03330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:09:06Z","timestamp":1581361746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-019-03330-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3330"],"URL":"https:\/\/doi.org\/10.1007\/s00431-019-03330-x","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"29 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical statements"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N. Guffon has received grants to institution and investigator fee for her participation in clinical trials with Chiesi, Sanofi, BioMarin, Shire HGT, and Sobi, and has received honoraria and travel support from Sanofi Genzyme, Shire HGT, and Chiesi to participate in scientific meetings.P. Journeau has received honorarium as advisor from Orthopediatrics and consulting fees from Sanofi Genzyme to participate in scientific meetings.A. Brassier has received honoraria and travel support from Sanofi Genzyme, Shire HGT, BioMarin, and Orphan Europe, to participate in scientific meetings, and investigator fees for her participation in clinical trials with Alexion.J. L\u00e9ger is currently an investigator in a clinical trial using growth hormone (GH) from Novo-Nordisk, support for travel to international meetings from several GH manufacturers (Ipsen, Merck, Novo Nordisk, Lilly), fees for lectures from Ipsen Pharma and Merck, and consulting fee from Sanofi Genzyme.B. Chevallier has no financial disclosure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}}]}}